Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	269.38	419.71	113.63
Graham Fair Price	-36.96	6.97	11.06
PEG	884.23	-2.64	0.27
Price/Book	56.37	27.09	17.32
Price/Cash Flow	-20.19	185.80	-232.81
Prices/Earnings	321.34	162.56	38.58
Price/Sales	83.65	54.17	29.50
Price/FCF	-20.19	185.80	-232.81
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-85.91	0.12	0.86
Operating Margin	-52.65	0.11	0.22
ROA	-63.30	0.02	0.06
ROE	0.11	0.04	-62.89
ROIC	0.10	0.04	-59.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	-0.15	-0.63	75.88
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.55	-0.58	-62.39
EPS QOQ	1.44	-0.62	-57.19
FCF QOQ	0.27	3.03	1010.80
Revenue QOQ	0.35	-0.12	-65.97
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	751.14	< 0.005	-100.00
Days Sales Outstanding (DSO)	62.27	64.01	2.79
Inventory Turnover	0.12	609912000.00	509032641585.60
Debt/Capitalization	0.02	0.02	-17.78
Quick Ratio	0.79	0.85	7.18
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	6.96	7.20	3.48
Cash	2.59	3.57	38.18
Capex	-0.82	-0.16	80.43
Free Cash Flow	-0.52	1.05	102.75
Revenue	4.09	3.60	-11.89
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.54	1.55	0.38
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.34	-7.55	-222.05
Naive Interpretation	Member

06 - Financial Health · Weak

Rating